Yorkshire Lung Screening Trial (YLST): protocol for a randomised controlled trial to evaluate invitation to community-based low-dose CT screening for lung cancer versus usual care in a targeted population at risk
Philip Crosbie(University of Manchester), Matthew Callister(University of Leeds), Rachael L Murray(University of Nottingham), Richard Booton(Manchester University NHS Foundation Trust), Suzanne Rogerson(Leeds Teaching Hospitals NHS Trust), Ann Cochrane(University of York), Rhian Gabe(Cancer Research UK), Nazia Ahmed(University of Leeds), Henrik Møller(Danish Institute for Quality and Accreditation in Healthcare), Mark Sculpher(University of York), Sam M. Janes(University College London), David Baldwin(University of Nottingham), Mike Messenger(University of Leeds), Richard D Neal(Bangor University), Samantha L. Quaife(Queen Mary University of London), Puvan Tharmanathan(University of York), Una Macleod(University of Hull), Sebastian Hinde(University of York), David Torgerson(University of York), Michael Darby(Leeds Teaching Hospitals NHS Trust), K. Franks(Leeds Teaching Hospitals NHS Trust), Martyn Kennedy(Leeds Teaching Hospitals NHS Trust), Irene Simmonds(University of Leeds)
Cited by 94
Related Papers
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women
|Osteoporosis International|2007|1.2k
Single-cell multi-omics analysis of the immune response in COVID-19
|Nature Medicine|2021|826
Guidelines for diagnosis and management of osteoporosis
|Osteoporosis International|1997|793